ArticleNeuro-oncology advances

An EZH2 blocker sensitizes histone mutated diffuse midline glioma to cholesterol metabolism inhibitors through an off-target effect.

Farah Rahal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.